New Study: States Could Save Up to $1.8 Billion Annually by Prioritizing Lower-Cost Biosimilar Medicines
At a time when states across the country are grappling with significant budget challenges, a new study from the Center for Medical Economics and Innovation at the Pacific Research Institute – the nonpartisan, California-based, free market think tank – finds that state employee health plans could save up to $1.8 billion every year by making greater use of lower-cost biosimilars. Click to download the study, The Biosimilar Savings Opportunity: Prioritizing Biosimilars Will Generate Significant Savings ...
Unauthorized GLP-1 Knockoffs Risk Patient Safety and Future Innovation, New PRI Brief Warns
As federal regulators intensify enforcement against companies selling unauthorized knockoffs of blockbuster weight-loss drugs, a new Pacific Research Institute brief warns that the booming GLP-1 knockoff market is creating patient safety risks while undermining future breakthrough medicines. “GLP-1s are among the most promising medical breakthroughs in decades, helping patients struggling with diabetes, obesity and other chronic illnesses,” said Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation and the brief’s author. “But ...
Trump’s healthcare fraud crackdown is paying off
Federal prosecutors recently announced that they’d charged 455 defendants in connection with more than $6.5 billion in alleged fraud involving Medicare, Medicaid, and other public healthcare programs. The news serves as a vivid reminder of just how much taxpayer money can disappear when oversight falls short. According to the Justice Department, the defendants include 90 doctors and other licensed medical professionals. Prosecutors also announced the largest Medicaid fraud operation in the department’s history, charging 295 ...
Trending Topics
Studies
